Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 49.92x is in line with its estimated 5-year average of 50.61x, around the middle of its estimated 5-year range (18.71x–70.91x).
As of 2026-10-06T21:53:25.829Z. 2.14% below its estimated 12-month average of 51.01x.
Calculation as of: 2026-10-06T21:53:25.829Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8cbf2c4bedb1eff0bddc45c0acac52f2eee77af7ab0e1536e55dbd1c791948ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
49.92x
EV/FCF RATIO AVG TTM
51.01x
EV/FCF RATIO AVG 3Y
51.01x
EV/FCF RATIO AVG 5Y
50.61x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.14%
CURRENT VS 3Y AVG
-2.14%
CURRENT VS 5Y AVG
-1.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
24.85x
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
+100.89%
vs the sector median at left
Tarsus Pharmaceuticals, Inc.
Market Cap
$3.19B
EV/FCF Ratio
49.92x
TTM Avg
51.01x
3Y Avg
51.01x
5Y Avg
50.61x
Market Cap
$3.12B
EV/FCF Ratio
N/A
TTM Avg
34.40x
3Y Avg
34.40x
5Y Avg
34.40x
Market Cap
$3.06B
EV/FCF Ratio
N/A
TTM Avg
15.31x
3Y Avg
19.99x
5Y Avg
19.99x
Market Cap
$3.38B
EV/FCF Ratio
17.60x
TTM Avg
24.95x
3Y Avg
51.13x
5Y Avg
51.13x
Market Cap
$2.99B
EV/FCF Ratio
78.47x
TTM Avg
109.02x
3Y Avg
109.02x
5Y Avg
109.02x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | $3.19B | 49.92x | 51.01x | 51.01x | 50.61x |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.12B | N/A | 34.40x | 34.40x | 34.40x |
| CareDx, Inc (CDNA)vs › | $3.30B | 34.64x | 28.10x | 179.80x | 179.80x |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | N/A | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.06B | N/A | 15.31x | 19.99x | 19.99x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.03B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 17.60x | 24.95x | 51.13x | 51.13x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $2.99B | 78.47x | 109.02x | 109.02x | 109.02x |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | N/A | N/A | N/A | N/A |
EV/FCF
49.9x
P/FCF
51.8x
FCF Yield
1.93%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-10-05 | 50.61x |
| 2026-10-02 | 49.58x |
| 2026-10-01 | 51.32x |
| 2026-09-30 | 53.54x |
| 2026-09-29 | 52.19x |
| 2026-09-28 | 52.27x |
| 2026-09-25 | 51.48x |
| 2026-09-24 | 51.67x |
| 2026-09-23 | 50.49x |
| 2026-09-22 | 52.46x |
| 2026-09-21 | 52.73x |
| 2026-09-18 | 53.17x |
| 2026-09-17 | 53.84x |
| 2026-09-16 | 52.86x |
| 2026-09-15 | 53.27x |
| 2026-09-14 | 54.48x |
| 2026-09-11 | 54.03x |
| 2026-09-10 | 55.31x |
| 2026-09-09 | 56.47x |
| 2026-09-08 | 59.61x |
| 2026-09-04 | 62.12x |
| 2026-09-03 | 56.78x |
| 2026-09-02 | 56.47x |
| 2026-09-01 | 50.33x |
| 2026-08-31 | 50.46x |
| 2026-08-28 | 48.71x |
| 2026-08-27 | 48.82x |
| 2026-08-26 | 47.93x |
| 2026-08-25 | 48.49x |
| 2026-08-24 | 49.45x |
| 2026-08-21 | 49.37x |
| 2026-08-20 | 48.52x |
| 2026-08-19 | 49.90x |
| 2026-08-18 | 48.20x |
| 2026-08-17 | 47.90x |
| 2026-08-14 | 46.91x |
| 2026-08-13 | 46.68x |
| 2026-08-12 | 47.48x |
| 2026-08-11 | 47.09x |
| 2026-08-10 | 45.89x |
| 2026-08-07 | 43.80x |
| 2022-05-11 | 25.04x |
| 2022-05-10 | 28.04x |
| 2022-05-09 | 19.75x |
| 2022-05-06 | 18.71x |
| 2022-05-05 | 25.04x |
| 2022-05-04 | 30.72x |
| 2022-05-03 | 31.57x |
| 2022-05-02 | 37.76x |
| 2022-04-29 | 65.89x |
| 2022-04-28 | 64.97x |
| 2022-04-27 | 65.89x |
| 2022-04-26 | 69.21x |
| 2022-04-25 | 70.91x |
| 2022-04-22 | 64.26x |
| 2022-04-21 | 65.69x |
| 2022-04-20 | 67.45x |
| 2022-04-19 | 65.23x |
| 2022-04-18 | 65.56x |
| 2022-04-14 | 66.34x |
| 2022-04-13 | 66.60x |
| 2022-04-12 | 62.56x |
| 2022-04-11 | 64.39x |
| 2022-04-08 | 61.97x |
| 2022-04-07 | 64.78x |
| 2022-04-06 | 62.69x |
| 2022-04-05 | 61.25x |
| 2022-04-04 | 60.34x |
| 2022-04-01 | 58.64x |
| 2022-03-31 | 56.16x |
| 2022-03-30 | 57.34x |
| 2022-03-29 | 60.60x |
| 2022-03-28 | 57.34x |
| 2022-03-25 | 59.56x |
| 2022-03-24 | 59.10x |
| 2022-03-23 | 62.04x |
| 2022-03-22 | 64.52x |
| 2022-03-21 | 60.60x |
| 2022-03-18 | 62.23x |
| 2022-03-17 | 63.86x |
| 2022-03-16 | 58.19x |
| 2022-03-15 | 61.97x |
| 2022-03-14 | 32.53x |
| 2022-03-11 | 36.63x |
| 2022-03-10 | 37.45x |
| 2022-03-09 | 40.20x |
| 2022-03-08 | 39.50x |
| 2022-03-07 | 38.01x |
| 2022-03-04 | 38.34x |
| 2022-03-03 | 38.08x |
| 2022-03-02 | 39.76x |
| 2022-03-01 | 38.34x |
| 2022-02-28 | 32.91x |
| 2022-02-25 | 33.32x |
| 2022-02-24 | 30.56x |
| 2022-02-23 | 23.64x |
| 2022-02-22 | 26.47x |
| 2022-02-18 | 26.84x |
| 2022-02-17 | 26.84x |
| 2022-02-16 | 28.14x |
| 2022-02-15 | 26.84x |
| 2022-02-14 | 24.79x |
| 2022-02-11 | 21.22x |
| 2022-02-10 | 27.02x |
| 2022-02-09 | 31.79x |
| 2022-02-08 | 31.57x |
| 2022-02-07 | 30.93x |
| 2022-02-04 | 32.61x |
| 2022-02-03 | 30.34x |
| 2022-02-02 | 33.24x |
| 2022-02-01 | 44.11x |
| 2022-01-31 | 41.99x |
| 2022-01-28 | 39.87x |
| 2022-01-27 | 35.21x |
| 2022-01-26 | 38.16x |
| 2022-01-25 | 39.12x |
| 2022-01-24 | 41.10x |
| 2022-01-21 | 31.98x |
| 2022-01-20 | 35.03x |
| 2022-01-19 | 37.75x |
| 2022-01-18 | 41.10x |
| 2022-01-14 | 44.52x |
| 2022-01-13 | 47.69x |
| 2022-01-12 | 49.18x |
| 2022-01-11 | 51.04x |
| 2022-01-10 | 49.81x |
| 2022-01-07 | 52.27x |
| 2022-01-06 | 52.38x |
| 2022-01-05 | 51.22x |
| 2022-01-04 | 56.18x |
| 2022-01-03 | 57.67x |
| 2021-12-31 | 51.04x |
| 2021-12-30 | 56.62x |
| 2021-12-29 | 56.62x |
| 2021-12-28 | 58.89x |
| 2021-12-27 | 62.28x |
| 2021-12-23 | 63.81x |
| 2021-12-22 | 63.14x |
| 2021-12-21 | 67.35x |
| 2021-12-20 | 57.11x |
| 2021-12-17 | 63.29x |
| 2021-12-16 | 61.84x |
| 2021-12-15 | 65.34x |
| 2021-12-14 | 60.16x |
| 2021-12-13 | 62.80x |
| 2021-12-10 | 55.58x |
| 2021-12-09 | 57.11x |
| 2021-12-08 | 59.42x |
| 2021-12-07 | 61.17x |
| 2021-12-06 | 58.00x |
| 2021-12-03 | 59.30x |
| 2021-12-02 | 64.07x |
| 2021-12-01 | 57.70x |
| 2021-11-30 | 66.30x |
| 2021-11-29 | 69.95x |
| 2021-11-26 | 60.35x |
| 2021-11-24 | 70.40x |
| 2021-11-23 | 68.54x |
| 2021-11-22 | 61.28x |
| 2021-11-19 | 60.61x |
| 2021-11-18 | 60.90x |
| 2021-11-17 | 61.31x |
| 2021-11-16 | 66.12x |
| 2021-11-15 | 62.43x |
| 2021-11-12 | 68.50x |
| 2021-11-11 | 69.62x |
